收藏切换
Development of Preparation Process for Cagrilintide
收藏切换
Yu DUAN1, Yuanzhen DONG1, 2, Chengcheng WANG2, Jianguang LU1, 2, Shuaiyi HUANG1, 2, Jun FENG1, 2, *
Chinese Journal of Pharmaceuticals | 2025, 56(8) : 1017 - 1026
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(8): 1017-1026
• Paper •
Development of Preparation Process for Cagrilintide
Full
Yu DUAN1, Yuanzhen DONG1, 2, Chengcheng WANG2, Jianguang LU1, 2, Shuaiyi HUANG1, 2, Jun FENG1, 2, *
Affiliations
  • 1.China State Institute of Pharmaceutical Industry, Shanghai 201203
  • 2.Shanghai Domirui Biotechnology Co., Ltd., Shanghai 201203
Published: 2025-08-10 doi: 10.16522/j.cnki.cjph.2025.08.007
Outline
收藏切换

Cagrilintide(1) is a long-acting lipidated analogue of amylin, and its compound preparation with semaglutide, known as CagriSema, has demonstrated a weight reduction effect of up to 22.7% in the latest phase Ⅲ clinical trials. However, the long amino acid sequence of 1 poses challenges for its synthesis and purification. In this paper, using Rink Amide AM resin as the carrier, Fmoc-protected amino acids as raw materials, ethyl cyanoglyoxylate-2-oxime/N,N'-diisopropylcarbodiimide as condensation reagents, and trifluoroacetic acid system as the lysis solution, the reduced crude peptide was synthesized by a solid phase peptide synthesis(SPPS) method from the C-terminus to the N-terminus of C20 diacid according to the amino acid sequence of 1. The intramolecular disulfide bonds were subsequently formed through iodine oxidation. The crude peptide was purified by RP-HPLC, affording a purified product with a purity of 98% and a total yield of 26%. Additionally, this study explored and optimized the preparation process parameters, providing valuable insights for industrial production of 1.

cagrilintide  /  anti-obesity drug  /  solid-phase synthesis  /  reverse purification  /  process development
段煜, 东圆珍, 王成成, 路建光, 黄帅义, 冯军. 卡格列肽的制备工艺开发. 中国医药工业杂志, 2025 , 56 (8) : 1017 -1026 . DOI: 10.16522/j.cnki.cjph.2025.08.007
Yu DUAN, Yuanzhen DONG, Chengcheng WANG, Jianguang LU, Shuaiyi HUANG, Jun FENG. Development of Preparation Process for Cagrilintide[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (8) : 1017 -1026 . DOI: 10.16522/j.cnki.cjph.2025.08.007
Year 2025 volume 56 Issue 8
30
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.08.007
  • Receive Date:2025-02-17
  • Online Date:2026-11-18
  • Published:2025-08-10
Article Data
Affiliations
History
  • Received:2025-02-17
Funding
Affiliations
    1.China State Institute of Pharmaceutical Industry, Shanghai 201203
    2.Shanghai Domirui Biotechnology Co., Ltd., Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.08.007
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT